Maternal neutralization-resistant virus variants do not predict infant HIV infection risk

mBio

Volumn 7, Issue 1, 2016, Pages

  Milligan, Caitlin ^a,b,c   Omenda, Maxwel M ^a,c   Chohan, Vrasha ^a,c   Odem Davis, Katherine ^a   Richardson, Barbra A ^a,c   Nduati, Ruth ^d   Overbaugh, Julie ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HIGH RISK INFANT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; LIMIT OF DETECTION; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; PLACENTAL TRANSFER; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS TITRATION; HUMAN IMMUNODEFICIENCY VIRUS; IC50; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RISK ASSESSMENT; SERODIAGNOSIS; TRANSMISSION; VERTICAL TRANSMISSION;

ANTIBODIES, NEUTRALIZING; FEMALE; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INHIBITORY CONCENTRATION 50; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT;

EID: 84960153998     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02221-15     Document Type: Article

References (43)

1. Evans DT, Silvestri G. 2013. Nonhuman primate models in AIDS research. Curr Opin HIV AIDS 8:255–261. http://dx.doi.org/10.1097/COH.0b013e328361cee8.
2. Sharma A, Boyd DF, Overbaugh J. 2015. Development of SHIVs with circulating, transmitted HIV-1 variants. J Med Primatol 44:296-300. http://dx.doi.org/10.1111/jmp.12179.
3. Hatziioannou T, Evans DT. 2012. Animal models for HIV/AIDS research. Nat Rev Microbiol 10:852-867. http://dx.doi.org/10.1038/nrmicro2911.
4. Lehman DA, Farquhar C. 2007. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 17: 381–403. http://dx.doi.org/10.1002/rmv.543.
5. Wu X, Parast AB, Richardson BA, Nduati R, John-Stewart G, Mbori- Ngacha D, Rainwater SM, Overbaugh J. 2006. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 80:835-844. http://dx.doi.org/10.1128/JVI.80.2.835-844.2006.
6. Zhang H, Rola M, West JT, Tully DC, Kubis P, He J, Kankasa C, Wood C. 2010. Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission. Virology 400: 164–174. http://dx.doi.org/10.1016/j.virol.2009.12.019.
7. Dickover R, Garratty E, Yusim K, Miller C, Korber B, Bryson Y. 2006. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J Virol 80:6525–6533. http://dx.doi.org/10.1128/JVI.02658-05.
8. Kliks SC, Wara DW, Landers DV, Levy JA. 1994. Features of HIV-1 that could influence maternal-child transmission. JAMA 272:467–474.
9. Ugen KE, Goedert JJ, Boyer J, Refaeli Y, Frank I, Williams WV, Willoughby A, Landesman S, Mendez H, Rubinstein A. 1992. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest 89:1923–1930.
10. Scarlatti G, Albert J, Rossi P, Hodara V, Biraghi P, Muggiasca L, Fenyö EM. 1993. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 168:207–210. http://dx.doi.org/10.1093/infdis/168.1.207.
11. Scarlatti G, Leitner T, Hodara V, Halapi E, Rossi P, Albert J, Fenyö EM. 1993. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 7(Suppl 2):S45–S48. http://dx.doi.org/10.1097/00002030-199311002-00010.
12. Lathey JL, Tsou J, Brinker K, Hsia K, Meyer WA, Spector SA. 1999. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-toinfant transmission. J Infect Dis 180:344–350.
13. Bongertz V, Costa CI, Veloso VG, Grinsztejn B, João Filho EC, Calvet G, Pilotto JH, Guimarães ML, Morgado MG. 2001. Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity. Scand J Immunol 53:302–309. http://dx.doi.org/10.1046/j.1365-3083.2001.00866.x.
14. Bongertz V, Costa CI, Veloso VG, Grinsztejn B, Filho EC, Calvet G, Pilotto JH. 2002. Neutralization titres and vertical HIV-1 transmission. Scand J Immunol 56:642-644. http://dx.doi.org/10.1046/j.1365-3083.2002.01174.x.
15. Barin F, Jourdain G, Brunet S, Ngo-Giang-Huong N, Weerawatgoompa S, Karnchanamayul W, Ariyadej S, Hansudewechakul R, Achalapong J, Yuthavisuthi P, Ngampiyaskul C, Bhakeecheep S, Hemwutthiphan C, Lallemant M, Perinatal HIV Prevention Trial Group. 2006. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J Infect Dis 193:1504–1511. http://dx.doi.org/10.1086/503778.
16. Samleerat T, Thenin S, Jourdain G, Ngo-Giang-Huong N, Moreau A, Leechanachai P, Ithisuknanth J, Pagdi K, Wannarit P, Sangsawang S, Lallemant M, Barin F, Braibant M. 2009. Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission. Virology 387:388-394. http://dx.doi.org/10.1016/j.virol.2009.02.024.
17. Diomede L, Nyoka S, Pastori C, Scotti L, Zambon A, Sherman G, Gray CM, Sarzotti-Kelsoe M, Lopalco L. 2012. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection. J Virol 86:4129–4138. http://dx.doi.org/10.1128/JVI.06359-11.
18. Chaillon A, Wack T, Braibant M, Mandelbrot L, Blanche S, Warszawski J, Barin F. 2012. The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1. J Virol 86:10540–10546. http://dx.doi.org/10.1128/JVI.00518-12.
19. Permar SR, Fong Y, Vandergrift N, Fouda GG, Gilbert P, Parks R, Jaeger FH, Pollara J, Martelli A, Liebl BE, Lloyd K, Yates NL, Overman RG, Shen X, Whitaker K, Chen H, Pritchett J, Solomon E, Friberg E, Marshall DJ, Whitesides JF, Gurley TC, Holle Von T, Martinez DR, Cai F, Kumar A, Xia S-M, Lu X, Louzao R, Wilkes S, Datta S, Sarzotti- Kelsoe M, Liao H-X, Ferrari G, Alam SM, Montefiori DC, Denny TN, Moody MA, Tomaras GD, Gao F, Haynes BF. 2015. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission. J Clin Invest 125:2702–2706. http://dx.doi.org/10.1172/JCI81593.
20. Broliden K, Sievers E, Tovo PA, Moschese V, Scarlatti G, Broliden PA, Fundaro C, Rossi P. 1993. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. Clin Exp Immunol 93:56-64. http://dx.doi.org/10.1111/j.1365-2249.1993.tb06497.x.
21. Husson RN, Lan Y, Kojima E, Venzon D, Mitsuya H, McIntosh K. 1995. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr 126:865–871. http://dx.doi.org/10.1016/S0022-3476(95)70198-2.
22. Hengel RL, Kennedy MS, Steketee RW, Thea DM, Abrams EJ, Lambert G, McDougal JS. 1998. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS Res Hum Retroviruses 14:475–481. http://dx.doi.org/10.1089/aid.1998.14.475.
23. Mabondzo A, Rouvier P, Raoul H, Le Naour R, Courpotin C, Hervé F, Parnet-Mathieu F, Lasfargues G, Dormont D. 1995. Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants. Clin Exp Immunol 102:476–480. http://dx.doi.org/10.1111/j.1365-2249.1995.tb03840.x.
24. Mabondzo A, Narwa R, Roques P, Gras GS, Hervé F, Parnet-Mathieu F, Lasfargues G, Courpotin C, Dormont D. 1998. Lack of correlation between vertical transmission of HIV-1 and maternal antibody titers against autologous virus in human monocyte-derived macrophages. J Acquir Immune Defic Syndr Hum Retrovirol 17:92–94. http://dx.doi.org/10.1097/00042560-199801010-00015.
25. Bal AK, Miller G, Viscarello R, Andiman WA. 1996. Syncytiuminhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1. Pediatr Infect Dis J 15:315–320. http://dx.doi.org/10.1097/00006454-199604000-00007.
26. Louisirirotchanakul S, Beddows S, Cheingsong R, Shaffer N, Mastro TD, Likanonsakul S, Wasi C, Taylor GP, Weber JN. 1999. Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand. J Acquir Immune Defic Syndr 21:259–265.
27. Kittinunvorakoon C, Morris MK, Neeyapun K, Jetsawang B, Buehring GC, Hanson CV. 2009. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response. J Med Virol 81:768–778. http://dx.doi.org/10.1002/jmv.21465.
28. Russell ES, Kwiek JJ, Keys J, Barton K, Mwapasa V, Montefiori DC, Meshnick SR, Swanstrom R. 2011. The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population. J Virol 85:8253–8262. http://dx.doi.org/10.1128/JVI.00197-11.
29. Omenda MM, Milligan C, Odem-Davis K, Nduati R, Richardson BA, Lynch J, John-Stewart G, Overbaugh J. 2013. Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection. J Acquir Immune Defic Syndr 64:163–166. http://dx.doi.org/10.1097/QAI.0b013e31829f6e41.
30. Guevara H, Casseb J, Zijenah LS, Mbizvo M, Oceguera LF III, Hanson CV, Katzenstein DA, Hendry RM. 2002. Maternal HIV-1 antibody and vertical transmission in subtype C virus infection. J Acquir Immune Defic Syndr 29:435-440. http://dx.doi.org/10.1097/00042560-200204150-00002.
31. Baan E, de Ronde A, Stax M, Sanders RW, Luchters S, Vyankandondera J, Lange JM, Pollakis G, Paxton WA. 2013. HIV-1 autologous antibody neutralization associates with mother to child transmission. PLoS One 8:e69274. http://dx.doi.org/10.1371/journal.pone.0069274.
32. Overbaugh J. 2014. Mother-infant HIV transmission: do maternal HIVNAb specific antibodies protect the infant? PLoS Pathog 10:e1004283. http://dx.doi.org/10.1371/journal.ppat.1004283.
33. Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, Bleeker WK, Parren PW, Marx PA, Burton DR. 2009. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 15:951–954. http://dx.doi.org/10.1038/nm.1974.
34. Shingai M, Donau OK, Plishka RJ, Buckler-White A, Mascola JR, Nabel GJ, Nason MC, Montefiori D, Moldt B, Poignard P, Diskin R, Bjorkman PJ, Eckhaus MA, Klein F, Mouquet H, Cetrulo Lorenzi JC, Gazumyan A, Burton DR, Nussenzweig MC, Martin MA, Nishimura Y. 2014. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J Exp Med 211:2061–2074. http://dx.doi.org/10.1084/jem.20132494.
35. Voronin Y, Chohan B, Emerman M, Overbaugh J. 2007. Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood. J Virol 81:10232–10241. http://dx.doi.org/10.1128/JVI.01035-07.
36. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, Ndinya-Achola J, Bwayo J, Onyango FE, Hughes J, Kreiss J. 2000. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167–1174. http://dx.doi.org/10.1001/jama.283.9.1167.
37. Heath L, Conway S, Jones L, Semrau K, Nakamura K, Walter J, Decker WD, Hong J, Chen T, Heil M, Sinkala M, Kankasa C, Thea DM, Kuhn L, Mullins JI, Aldrovandi GM. 2010. Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One 5:e10213. http://dx.doi.org/10.1371/journal.pone.0010213.
38. Salazar-Gonzalez JF, Salazar MG, Learn GH, Fouda GG, Kang HH, Mahlokozera T, Wilks AB, Lovingood RV, Stacey A, Kalilani L, Meshnick SR, Borrow P, Montefiori DC, Denny TN, Letvin NL, Shaw GM, Hahn BH, Permar SR, Center for HIV/AIDS Vaccine Immunology A0167854. 2011. Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J Virol 85:2751–2763. http://dx.doi.org/10.1128/JVI.02316-10.
39. John GC, Nduati RW, Mbori-Ngacha DA, Richardson BA, Panteleeff D, Mwatha A, Overbaugh J, Bwayo J, Ndinya-Achola JO, Kreiss JK. 2001. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 183:206–212. http://dx.doi.org/10.1086/317918.
40. Rousseau CM, Nduati RW, Richardson BA, John-Stewart GC, Mbori- Ngacha DA, Kreiss JK, Overbaugh J. 2004. Association of levels of HIV- 1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 190:1880–1888. http://dx.doi.org/10.1086/425076.
41. Long EM, Rainwater SM, Lavreys L, Mandaliya K, Overbaugh J. 2002. HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. AIDS Res Hum Retroviruses 18:567–576. http://dx.doi.org/10.1089/088922202753747914.
42. Rainwater SM, Wu X, Nduati R, Nedellec R, Mosier D, John-Stewart G, Mbori-Ngacha D, Overbaugh J. 2007. Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. Curr HIV Res 5:189-197. http://dx.doi.org/10.2174/157016207780076986.
43. Becquart P, Chomont N, Roques P, Ayouba A, Kazatchkine MD, Bélec L, Hocini H. 2002. Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 300:109-117. http://dx.doi.org/10.1006/viro.2002.1537.